Announced
Completed
Synopsis
Dallmann’s Pharma, a company of Katjes International, which manufactures and sells confectionery products, completed the acquisition of Bubchen, a recognized skincare brand in Germany, from Galderma, an independent global dermatology company, for $20m. “I am delighted we have identified the right partner to take over the Bübchen business. It brings a new German home with the right focus for the much-loved Bübchen brand and for the passionate teams behind it, where it will continue to thrive into the future,” Flemming Orsnkov, Galderma CEO.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.